D1-03: Treatment with irinotecan plus carboplatin prolongs survival without compromising quality of life in patients with small cell lung cancer, extensive disease (SCLC-ED). Results of a randomized phase III trial
2007
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
3
Citations
NaN
KQI